Lifecare ASA
LIFE | OL
Overview
Corporate Details
- ISIN(s):
- NO0013250563 (+2 more)
- LEI:
- 254900D88MYGZ7JD5P39
- Country:
- Norway
- Address:
- Ytrebygdsvegen 215, 5158 Bergen
- Website:
- https://lifecare.no/
- Sector:
- Manufacturing
- Industry:
- Manufacture of medical and dental instruments and supplies
Description
Lifecare ASA is a clinical-stage medical sensor company developing proprietary nanotechnology for medical monitoring. Its core Sencell technology utilizes osmotic pressure to enable miniaturized, implantable nanobiosensors that can measure various body analytes. The company's primary focus is on diabetes management, with the goal of creating a next-generation Continuous Glucose Monitoring (CGM) system that is painless, accurate, and offers long-term use for both human and veterinary patients. Lifecare is advancing its technology through clinical development and process automation to achieve regulatory approval and commercialization. The company also licenses its technology platform for broader medical and lifestyle applications.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Lifecare ASA.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-27 07:00 |
Regulatory News Service
Reconfirmed positive results in veterinary study support path toward market ent…
|
English | 64.0 KB | |
| 2025-08-27 07:00 |
Regulatory News Service
Reconfirmed positive results in veterinary study support path toward market ent…
|
English | 4.6 KB | |
| 2025-08-20 07:00 |
Investor Presentation
LIFE: Lifecare ASA Q2 2025 results - Attachment: Lifecare Q2 2025 Presentation.…
|
English | 2.5 MB | |
| 2025-08-20 07:00 |
Quarterly Report
LIFE: Lifecare ASA Q2 2025 results - Attachment: Lifecare Q2 2025 Report.pdf
|
English | 742.4 KB | |
| 2025-08-20 07:00 |
Earnings Release
LIFE: Lifecare ASA Q2 2025 results
|
English | 4.1 KB | |
| 2025-08-13 07:47 |
Regulatory News Service
Lifecare advances CE mark preparation for its groundbreaking medical device - A…
|
English | 57.3 KB | |
| 2025-08-13 07:47 |
Regulatory News Service
Lifecare advances CE mark preparation for its groundbreaking medical device
|
English | 4.1 KB | |
| 2025-08-12 14:35 |
Report Publication Announcement
Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at…
|
English | 60.8 KB | |
| 2025-08-12 14:35 |
Report Publication Announcement
Lifecare ASA (LIFE): Invitation to presentation of Q2 2025 results 20 August at…
|
English | 1.8 KB | |
| 2025-08-05 07:00 |
Regulatory News Service
Lifecare receives ethics approval to initiate first-in-human trial in Norway - …
|
English | 56.7 KB | |
| 2025-08-05 07:00 |
Legal Proceedings Report
Lifecare receives ethics approval to initiate first-in-human trial in Norway
|
English | 3.3 KB | |
| 2025-07-08 07:00 |
Regulatory News Service
Lifecare achieves full radio frequency compliance for CGM implant clearing th…
|
English | 57.9 KB | |
| 2025-07-08 07:00 |
Regulatory News Service
Lifecare achieves full radio frequency compliance for CGM implant clearing th…
|
English | 3.9 KB | |
| 2025-07-01 07:00 |
Regulatory News Service
Lifecare advances electromagnetic compatibility compliance testing for CGM impl…
|
English | 56.0 KB | |
| 2025-07-01 07:00 |
Regulatory News Service
Lifecare advances electromagnetic compatibility compliance testing for CGM impl…
|
English | 3.2 KB |
Automate Your Workflow. Get a real-time feed of all Lifecare ASA filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Lifecare ASA via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
